Overview

This bill amends the Mesothelioma Act 2014 to add a research supplement to the existing levy on insurers. This supplement will fund research into mesothelioma, a cancer linked to asbestos exposure.

Description

The Mesothelioma (Amendment) (No. 2) Bill modifies the 2014 Act by introducing a "research supplement" to the levy paid by insurers. This supplement:

• Will be a percentage (up to 1%) of the existing levy.
• Will be used to fund research into mesothelioma through grants or other financial assistance.
• Will be administered by the scheme administrator, potentially with the help of a research funding body.
• May allow for the accumulation and investment of funds before allocation.

Before implementing the supplement, the Secretary of State must consult insurers, medical charities and research foundations, and other relevant parties.

Government Spending

The bill will not directly increase or decrease government spending. Instead, it will create a new source of funding (the research supplement) for mesothelioma research, drawn from the existing levy on insurers.

Groups Affected

• Insurers: Will pay a slightly higher levy to fund the research supplement.
• Mesothelioma sufferers and their families: May indirectly benefit from improved treatments and prevention strategies resulting from the funded research.
• Medical charities and research foundations: Could receive funding for mesothelioma research.
• Researchers: May receive funding for their research projects.

Powered by nyModel